Literature DB >> 10860774

IL-1 beta increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes.

M Patten1, W Wang, S Aminololama-Shakeri, M Burson, C S Long.   

Abstract

Current research from both clinical and basic science perspectives indicates that cytokines play an important role in the genesis of cardiovascular pathology. Specifically, levels of cytokines such as interleukin-1 (IL-1), tumor necrosis factor- alpha (TNF- alpha), and interleukin-6 (IL-6) have been found to be elevated in both acute myocardial injury as well as situations of chronic dysfunction. Further, therapies directed primarily at interfering with cytokine action have suggested that such an immunomodulatory approach may be beneficial in some of these circumstances of myocardial injury. We recently reported that IL-1 beta induces a hypertrophic state in cultured neonatal rat cardiac myocytes that differs from other well described hypertrophic phenotypes in terms of myocardial gene expression (such as skeletal alpha -actin, sACT), an effect that appeared to co-localize with that of the negative regulator yin yang-1 (YY1).(1)In the present study, we further localize the area in the sACT promoter responsible for the IL-1 effect. These investigations indicate that sequences in and around the third upstream serum response element (SRE3) bind YY1 and are required for IL-1 beta mediated repression. This element is also capable of transferring both IL-1 beta and YY1-mediated transcriptional repression to a heterologous promoter. In support of an IL-1 beta induced post-translational modification of YY1 that results in an increase in DNA-binding activity,(32)P-labeling experiments reveal an increase in phosphorylated YY1 in IL-1 beta treated cells and phosphatase-treated myocyte nuclear proteins lose their ability to bind to the YY1 site. In summary, these results provide evidence that sequences within the SRE3 of the skeletal actin promoter represent an IL-1 beta response element and suggest that IL-1 beta activates the negative transcription factor YY1 by both transcriptional and post-transcriptional mechanisms. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860774     DOI: 10.1006/jmcc.2000.1169

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

1.  Transgenic over-expression of YY1 induces pathologic cardiac hypertrophy in a sex-specific manner.

Authors:  Brian L Stauffer; Karen Dockstader; Gloria Russell; Jamie Hijmans; Lisa Walker; Mackenzie Cecil; Kimberly Demos-Davies; Allen Medway; Timothy A McKinsey; Carmen C Sucharov
Journal:  Biochem Biophys Res Commun       Date:  2015-04-29       Impact factor: 3.575

Review 2.  The role of interleukin-1 in the failing heart.

Authors:  C S Long
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

3.  Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor alpha1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase.

Authors:  Koichiro Kinugawa; Mark Y Jeong; Michael R Bristow; Carlin S Long
Journal:  Mol Endocrinol       Date:  2005-04-14

4.  Decreased miR-29 suppresses myogenesis in CKD.

Authors:  Xiaonan H Wang; Zhaoyong Hu; Janet D Klein; Liping Zhang; Fude Fang; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2011-09-30       Impact factor: 10.121

5.  NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.

Authors:  Huating Wang; Erin Hertlein; Nadine Bakkar; Hao Sun; Swarnali Acharyya; Jingxin Wang; Micheal Carathers; Ramana Davuluri; Denis C Guttridge
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

6.  Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.

Authors:  Roberta L DeBiasi; Bridget A Robinson; Barbara Sherry; Ron Bouchard; R Dale Brown; Mona Rizeq; Carlin Long; Kenneth L Tyler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5.

Authors:  Carmen C Sucharov; Karen Dockstader; Timothy A McKinsey
Journal:  Mol Biol Cell       Date:  2008-07-16       Impact factor: 4.138

8.  Sphingosine-1-phosphate and endothelin-1 induce the expression of rgs16 protein in cardiac myocytes by transcriptional activation of the rgs16 gene.

Authors:  Sabine Stuebe; Thomas Wieland; Elisabeth Kraemer; Alexandra v Stritzky; Diana Schroeder; Sünje Seekamp; Andreas Vogt; Ching-Kang Chen; Monica Patten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-29       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.